期刊： BIOTECHNOLOGY LAW REPORT, 2022; 41 (6)
As biologic drugs are gaining attention worldwide, the biopharmaceutical industry in China has developed rapidly in recent years. The People's Republi......
期刊： BIOTECHNOLOGY LAW REPORT, 2022; 41 (4)
The early dispute resolution mechanism created a new foundation for pharmaceutical innovation and expanding access to generics in China. This article ......
期刊： BIOTECHNOLOGY LAW REPORT, 2022; 41 (6)
In the era of smart health care, artificial intelligence technology has penetrated the medical field, resulting in a number of new inventions with dis......
期刊： BIOTECHNOLOGY LAW REPORT, 2021; 40 (2)
Biosafety and technology innovation have been drawing wide attention in the biological and medical fields. With the dramatic development of biotechnol......
期刊： BIOTECHNOLOGY LAW REPORT, 2020; 39 (3)
This article takes the reality in China as its basis and examines the meaning of "production or business purpose" in Article 11 of the Chinese Patent ......
期刊： BIOTECHNOLOGY LAW REPORT, 2020; 39 (4)
In recent years, China has paid much more attention to its pharmaceutical policy than ever, and forecasting policy on pharmaceutical patent protection......
期刊： BIOTECHNOLOGY LAW REPORT, 2019; 38 (3)
China is the world's largest vaccine producer and consumer, mainly using domestic vaccines. However, many of the vaccines produced domestically have e......
期刊： BIOTECHNOLOGY LAW REPORT, 2019; 38 (4)
China has begun to plant and use genetically modified organisms (GMOs) in large quantities, and the cautious Chinese government has enacted several la......
期刊： BIOTECHNOLOGY LAW REPORT, 2019; 38 (5)
The Food Safety Law of China, which was updated and revised in 2015, has clarified the responsibility system for third-party platform providers of the......
